Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet AUGTYRO 40mg capsules
- Product code:
- W72085001
- Quantity:
- 60
- Indicated for:
- advanced ROS1-positive non-small cell lung cancer in adults; advanced NTRK fusion-positive solid tumours in eligible pat
- Route of administration:
- oral
- Substance:
- repotrectinib (ROS1/TRK tyrosine kinase inhibitor)
- ATC
- L01EX28 — Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors
Precautions:
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
General warning
Read the package leaflet before use.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Avoid grapefruit
Avoid grapefruit and grapefruit juice.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Neuropathy / neurotoxicity
This medicine may affect the nerves or nervous system.
Do not split / crush / chew
Do not split, crush, or chew this medicine.
Pregnancy warning
Use during pregnancy only on medical advice.
Pediatric warning
Use in children only as recommended in the leaflet or by a doctor.
Teratogenic / fetal risk
This medicine may affect fetal development.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
General data about AUGTYRO 40mg
- Substance:
- repotrectinib
- Date of latest medicines list:
- 01-09-2026
- Product code:
- W72085001
- Concentration:
- 40mg
- Pharmaceutical form:
- capsules
- Quantity:
- 60
- Product type:
- Generic medicine
- Price:
- 24017.28 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.